Sign inJoin waitlistJoin the waitlist

CF

Christopher Forlenza

Physician · Memorial Hospital for Cancer and allied Diseases

Credentials: · ·

History

Memorial Hospital for Cancer and allied Diseases
2020–Present

Hematology and Medical Oncology
New York Presbyterian Hospital
2011–2014
Montefiore Medical Center/Albert Einstein College of Medicine
2008–2011
New York University Grossman School of Medicine
2004–2008

Research

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
Blood · 2019 · 238 citations
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
New England Journal of Medicine · 2024 · 205 citations
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
Nature Cancer · 2021 · 146 citations

NS
Neerav Shukla
11 papers
Kavitha Ramaswamy
7 papers · 1 as a fellow
Sharon Castellino
7 papers
Kara Kelly
6 papers
PS
Peter Steinherz
6 papers
TT
Tanya Trippett
6 papers
MS
Maria Sulis
5 papers
Brad Hoppe
4 papers
NK
Nancy Kernan
4 papers
FK
Frank Keller
3 papers
JB
Jaap-Jan Boelens
3 papers
Justine Kahn
3 papers

Clinical trials

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Site PI · Recruiting
St. Jude Children's Research Hospital
2024–2028
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031